E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/18/2005 in the Prospect News Biotech Daily.

Connetics at hold by Jefferies

Connetics Corp. was rated hold with a $17.00 price target by Jefferies & Co., Inc. analysts David H. Windley and Himanshu Rastogi. They said all four products the company markets are behind Jefferies' forecast, with Evoclin trailing most behind. Connetics shares closed Thursday down $0.01, or 0.06%, at $17.64 on volume of 256,073 shares versus a three-month trailing average of 931,026 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.